- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00691561
Culturally-Tailored HIV Risk Reduction for African-American MSM (Project ABLE)
March 10, 2010 updated by: Medical College of Wisconsin
Culturally-Tailored HIV Risk Reduction for African-American MSM (Project ABLE: African-Americans Building Life Empowerment
The purpose of this study to conduct a small randomized control trial to compare the relative effectiveness of a single-session of HIV testing and counseling risk reduction intervention (HCT-only) to an enhanced intervention that includes the standard HCT intervention plus a theory-based and culturally-tailored group-level intervention designed to reduce or eliminate HIV and STI risk behaviors (HCT-plus) among African-American men who have sex with men (AA-MSM).
Study Overview
Detailed Description
The HCT-plus intervention will consist of the HCT-only intervention, as well as 8 small group intervention sessions focused on HIV risk reduction.
Small groups will consist of 10 men who will meet once-a-week for 8 consecutive weeks.
Each meeting will last approximately 2 hours.
In each small group session, staff will work with men to reassess their HIV risk behavior, re-prioritize their goals as appropriate, and provide motivational support for their risk reduction accomplishments.
Participants will be asked to discuss ways they have successfully avoided HIV risk behavior since the previous session, as well as to discuss situations in which they found it difficult to avoid risk.
Staff will reinforce successful risk avoidance, and problem-solve with men to overcome barriers to risk reduction.
Study Type
Interventional
Enrollment (Anticipated)
220
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Wisconsin
-
Milwaukee, Wisconsin, United States, 53202
- Diverse and Resilient
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
- reside in Milwaukee county;
- are at least 18 years of age;
- self-identify as male;
- self-identify as Black or African-American;
- can provide informed consent;
- report unprotected anal sex with a man in the past 3 months;
- report at least two sexual partners with whom they have had unprotected anal or vaginal sex in the past 3 months;
- are willing to be tested for HIV using rapid oral fluid procedures or willing to provide evidence of HIV seropositivity
Exclusion Criteria:
- Under 18 years of age,
- involvement in a HIV prevention study currently or in the past 6 months,
- Participation in the pilot phase
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: 1
Participants receive HIV counseling and testing and 8 intervention sessions to assist them with reducing unsafe sexual behaviors.
|
Participants will receive HIV counseling and testing.
Those selected for the intervention arm will attend small groups consisting of 10 men who meet once a week for 8 consecutive weeks.
The weekly two hour discussion sessions will address HIV risk behavior within a framework of contextual influences that may moderate men's risk reduction motivation and behavior.
The factors include identity, stigma, connections to community, and situation factors.
|
|
No Intervention: 2
Participants receive HIV counseling and testing only.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The HCT-plus intervention will result in a greater proportion of men who abstain from anal and vaginal intercourse.
Time Frame: 3 months after completing intervention
|
3 months after completing intervention
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
The HCT-plus intervention will result in a smaller proportion of men who had an act of anal or vaginal intercourse without the use of a condom.
Time Frame: 3 months after completing the intervention
|
3 months after completing the intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: David Seal, PhD, Medical College of Wisconsin
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2008
Primary Completion (Actual)
March 1, 2010
Study Completion (Actual)
March 1, 2010
Study Registration Dates
First Submitted
June 3, 2008
First Submitted That Met QC Criteria
June 4, 2008
First Posted (Estimate)
June 5, 2008
Study Record Updates
Last Update Posted (Estimate)
March 11, 2010
Last Update Submitted That Met QC Criteria
March 10, 2010
Last Verified
March 1, 2010
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CDC-NCHHSTP-5394
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Infections
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
CAN Community HealthGilead Sciences; Midway Specialty Care Center; Costello Medical Inc.Not yet recruitingHIV | HIV 1 Infection | HIV -1 Infection | HIV (Human Immunodeficiency Virus)United States
-
University of California, San DiegoUniversity of California, Los Angeles; University of Southern California; California... and other collaboratorsCompleted
-
Gérond'ifRecruiting
-
University of California, DavisCompleted
-
University of California, San DiegoNational Center for Complementary and Integrative Health (NCCIH)CompletedHIV PositiveUnited States
-
University of ChicagoUniversity of Athens; National Development and Research Institutes, Inc.Completed
-
University of ZimbabweCompleted
-
Florida International UniversityCompleted
-
Boston Children's HospitalNational Institute on Minority Health and Health Disparities (NIMHD)Completed
Clinical Trials on Project ABLE
-
ABLE Human Motion S.L.therapy2people GmbHRecruitingMultiple Sclerosis | Spinal Cord Injury | Acquired Brain Injury (Including Stroke)Austria
-
ABLE Human Motion S.L.Institut Guttmann; Heidelberg University Hospital Spinal Cord Injury CenterCompleted
-
ABLE Human Motion S.L.Fundación Esclerosis Múltiple Madrid (FEMM)Completed
-
Parker Research InstituteVIA University College; University of Southern DenmarkCompletedChronic Conditions, MultipleDenmark
-
ABLE Human Motion S.L.Sint Maartenskliniek; Universitat Politècnica de CatalunyaRecruitingSpinal Cord InjuryNetherlands
-
ABLE Human Motion S.L.Fundación Esclerosis Múltiple Madrid (FEMM)CompletedMultiple SclerosisSpain
-
ABLE Human Motion S.L.Centro Europeo de Neurociencias (CEN); Cefine Neurología (CEFINE); Fundación...CompletedAcquired Brain Injury (Including Stroke)Spain
-
ABLE Human Motion S.L.University Hospital Heidelberg; Institut GuttmannCompleted
-
ABLE Human Motion S.L.Hospital ASEPEYO Sant CugatCompleted
-
ABLE Human Motion S.L.Hospital Asepeyo Barcelona; Biomechanical Engineering Lab (BIOMEC) - Universitat... and other collaboratorsCompleted